Native Antigen releases coronavirus antigens

2020 01 27 21 38 4451 Lab 2019 Coronavirus Test 400

The Native Antigen Co. has introduced a line of coronavirus antigens from the emerging Wuhan strain, a move it said will support research and the development of diagnostics and vaccines.

The antigens were derived from the novel coronavirus (2019-nCoV) using the company's proprietary VirtuE expression system. The system introduces proper protein folding and post-translational modifications to recombinant proteins, which are essential for full biological and antigenic activity, according to the company.

Page 1 of 70
Next Page